SNDL Inc.

Healthcare

NASDAQ:SNDL · NASDAQ Capital Market

Market Cap $377.25M Beta 0.91 P/E (TTM) -47.1

$1.42 -2.74%

-$0.04 today

52W Low $1.15High $2.89

Vol 2.20M · Avg 2.06M

EPS (TTM)-$0.04

Drug Manufacturers - Specialty & Generic

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+10.08%

Period High

$2.82

Period Low

$1.21

Latest

$1.42

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

COMPASS Pathways plc

NASDAQ:CMPS

$1.16B

Corvus Pharmaceuticals, Inc.

NASDAQ:CRVS

$1.00B

Olema Pharmaceuticals, Inc.

NASDAQ:OLMA

$862.12M

Esperion Therapeutics, Inc.

NASDAQ:ESPR

$654.91M

Evolus, Inc.

NASDAQ:EOLS

$443.20M

Emergent BioSolutions Inc.

NYSE:EBS

$429.28M

Aquestive Therapeutics, Inc.

NASDAQ:AQST

$414.11M

SIGA Technologies, Inc.

NASDAQ:SIGA

$309.85M

Organogenesis Holdings Inc.

NASDAQ:ORGO

$301.10M

Akebia Therapeutics, Inc.

NASDAQ:AKBA

$248.00M

What is the latest SNDL filing?

The latest filing shown is 6-K dated May 28, 2026.

How many recent filings does SNDL have?

Intrinsic Alpha currently shows 20 recent filings for SNDL.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.